Kyverna Therapeutics Inc (NASDAQ: KYTX) is -86.50% lower on its value in year-to-date trading and has touched a low of $3.62 and a high of $35.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KYTX stock was last observed hovering at around $3.92 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $3.96, the stock is -15.16% and -18.74% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.12 million and changing 1.02% at the moment leaves the stock -62.19% off its SMA200. KYTX registered a loss of -44.29% in past 6-months. The firm has a 50-day simple moving average (SMA 50) of $4.9047 and a 200-day simple moving average (SMA200) of $10.59995.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -7.74% gain in the last 1 month and extending the period to 3 months gives it a -22.71%, and is -3.34% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.10% over the week and 10.93% over the month.
Kyverna Therapeutics Inc (KYTX) has around 96 employees, a market worth around $172.70M and $0.00M in sales. Distance from 52-week low is 9.24% and -88.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-35.94%).
The EPS is expected to grow by 96.32% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Kyverna Therapeutics Inc (KYTX) Top Institutional Holders
The shares outstanding are 43.17M, and float is at 18.72M with Short Float at 13.83%.
Kyverna Therapeutics Inc (KYTX) Insider Activity
The most recent transaction is an insider purchase by Vida Ventures, LLC, the company’s 10% Owner. SEC filings show that Vida Ventures, LLC bought 253,136 shares of the company’s common stock on Feb 12 ’24 at a price of $22.00 per share for a total of $5.57 million. Following the purchase, the insider now owns 0.25 million shares.
Kyverna Therapeutics Inc disclosed in a document filed with the SEC on Feb 12 ’24 that Bain Capital Life Sciences Inv (10% Owner) bought a total of 450,000 shares of the company’s common stock. The trade occurred on Feb 12 ’24 and was made at $22.00 per share for $9.9 million. Following the transaction, the insider now directly holds 3.16 million shares of the KYTX stock.
Still, SEC filings show that on Feb 12 ’24, GILEAD SCIENCES, INC. (10% Owner) acquired 910,000 shares at an average price of $22.00 for $20.02 million. The insider now directly holds 4,126,119 shares of Kyverna Therapeutics Inc (KYTX).
